ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Guoqin Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7666-9550; OpenAlex author ID A5073317136. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Active fragment assembly strategy enabling fast discovery of KRAS inhibitors against pancreatic cancer cells. Last author DOI 10.1016/j.ejmech.2026.118807 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kan Ding · 1 shared paper, 2026 · strength 0.30
- Paper Active fragment assembly strategy enabling fast discovery of KRAS inhibitors against pancreatic cancer cells. DOI 10.1016/j.ejmech.2026.118807 ↗
Pengli Zhang · 1 shared paper, 2026 · strength 0.30
- Paper Active fragment assembly strategy enabling fast discovery of KRAS inhibitors against pancreatic cancer cells. DOI 10.1016/j.ejmech.2026.118807 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.